Company intelligence / Profile preview

M2 Enterprises

Saint-Cloud, Île-de-France, France

Ownership: Private
Employees: ~200
Development stage: Other

Overview

M2i Life Sciences is a leading French biotechnology company specializing in the design, synthesis, and production of pheromones for biological pest control. The company provides environmentally friendly alternatives to traditional chemical pesticides for use in agriculture, forestry, and public health sectors. M2i operates as an integrated player, combining advanced R&D in chemical synthesis with large-scale manufacturing capabilities. In addition to its proprietary product line, the company offers contract research (CRO) and contract development and manufacturing (CDMO) services to industrial partners in the life sciences and fine chemistry industries.

Therapeutic areas: OtherInfectious Diseases
Modalities: Small moleculePheromonesBiocontrol
Industry: Agriculture & AgTech

Partnerships

ADAMASyngenta

Beyond the preview

Go deeper on M2 Enterprises.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on M2 Enterprises.

Explore the full profile